Skip to main content
. 2020 Mar 27;301(5):1247–1255. doi: 10.1007/s00404-020-05505-6

Fig. 3.

Fig. 3

Plot of Kaplan–Meier estimates for disease free survival (a) and overall survival (b) for the patients with optimal response in the NACT + RS group compared to the RS group and for disease free survival (c) and overall survival (d) for the patients with optimal response in the NACRT + RS group compared to the RS group. NACT neoadjuvant chemotherapy, RS radical surgery, NACRT neoadjuvant chemoradiation therapy